Nephurocare Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.20 Cr
- Satisfied Charges ₹ 1.10 Cr
- Revenue Growth 12.86%
- Profit Growth -2.19%
- Ebitda 45.24%
- Net Worth 7.53%
- Total Assets 9.30%
About Nephurocare Pharma
Nephurocare Pharma Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 November 2010 and has a history of 14 years and three months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Nerve Biosciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹2.20 Cr. The company has closed loans amounting to ₹1.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jashvant Prahladbhai, Satyajit Bhatt, Snehal Vaishnav, and Four other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230GJ2010PTC062880
- Company No.
062880
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Nephurocare Pharma Private Limited offer?
Nephurocare Pharma Private Limited offers a wide range of products and services, including Vitamins & Supplements, Mineral Supplements, Health Conditions, Kidney Care.
Who are the key members and board of directors at Nephurocare Pharma?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Snehal Vaishnav  | Director | 04-Sep-2014 | Current |
| Shailesh Rameshchandra | Director | 01-Apr-2015 | Current |
| Jashvant Prahladbhai | Director | 10-Sep-2014 | Current |
| Satyajit Bhatt | Director | 11-Nov-2010 | Current |
| Viral Shah | Director | 04-Sep-2014 | Current |
| Sandip Sureshrav | Director | 18-Sep-2014 | Current |
Financial Performance of Nephurocare Pharma.
Nephurocare Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.86% increase. The company also saw a slight decrease in profitability, with a 2.19% decrease in profit. The company's net worth moved up by a moderate rise of 7.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nephurocare Pharma?
In 2023, Nephurocare Pharma had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aiocd Pharma LimitedJashvant Prahladbhai is a mutual person
- Shriji Distributor Sd Private Limited
Jashvant Prahladbhai is a mutual person
- Synergetic Secure Solutions Private Limited
Jashvant Prahladbhai and Nitinkumar Patel are mutual person
- Accuhawk Private Limited
Jashvant Prahladbhai is a mutual person
- Xylis Wellness Llp
Nitinkumar Patel is a mutual person
Charges (Loans)
₹22.00 M
₹11.02 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 2.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Oct 2023 | Hdfc Bank Limited | ₹7.00 M | Open |
| 15 Jun 2023 | Hdfc Bank Limited | ₹1.50 Cr | Open |
| 28 Nov 2017 | Others | ₹7.02 M | Satisfied |
| 01 Mar 2017 | Others | ₹4.00 M | Satisfied |
How Many Employees Work at Nephurocare Pharma?
Nephurocare Pharma has a workforce of 21 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nephurocare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nephurocare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
